|
| 36634297 | Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. | JCO Precis Oncol | 2023 |
| 37856201 | NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. | J Natl Compr Canc Netw | 2023 |
| 37572151 | PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer. | Fam Cancer | 2023 |
| 36989360 | Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. | Sci Adv | 2023 |
| 37079292 | Is Appendiceal Cancer a Lynch Syndrome-Associated Cancer? | JAMA Oncol | 2023 |
| 37402979 | Serendipity Strikes: How Pursuing Novel Hypotheses Shifted the Paradigm Regarding the Genetic Basis of Colorectal Cancer and Changed Cancer Therapy. | Dig Dis Sci | 2023 |
| 37463915 | Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. | Nat Commun | 2023 |
| 37463056 | Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer. | Clin Cancer Res | 2023 |
| 36549470 | Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines. | Clin Gastroenterol Hepatol | 2023 |
| 36807743 | Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer. | Oncologist | 2023 |
| 36773823 | Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort. | J Am Acad Dermatol | 2023 |
| 36672340 | MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome. | Cancers (Basel) | 2023 |
| 36702949 | Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial. | Nat Med | 2023 |
| 34798988 | Lynch Syndrome-Associated Cancers Beyond Colorectal Cancer. | Gastrointest Endosc Clin N Am | 2022 |
| 35380713 | Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial. | Oncologist | 2022 |
| 35649230 | Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for All GI Cancers? | J Clin Oncol | 2022 |
| 35722047 | Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study. | BMJ Open Sport Exerc Med | 2022 |
| 35363308 | Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program. | Clin Cancer Res | 2022 |
| 35862875 | Building on More Than 20 Years of Progress in Pancreatic Cancer Surveillance for High-Risk Individuals. | J Clin Oncol | 2022 |
| 35960913 | Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment. | J Clin Oncol | 2022 |
| 36265995 | Preface. | Hematol Oncol Clin North Am | 2022 |
| 36091175 | An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes. | Front Oncol | 2022 |
| 36222830 | An updated counseling framework for moderate-penetrance colorectal cancer susceptibility genes. | Genet Med | 2022 |
| 36322852 | Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas. | N Engl J Med | 2022 |
| 36049831 | The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice. | Surg Pathol Clin | 2022 |
| 33611683 | Managing gastric cancer risk in lynch syndrome: controversies and recommendations. | Fam Cancer | 2022 |
| 34954223 | Surveillance Imaging in Individuals at High Risk for Pancreatic Cancer: Not a Ceiling, but Rather a Floor Upon Which to Build. | Gastroenterology | 2022 |
| 35001450 | Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. | J Genet Couns | 2022 |
| 32743790 | Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals. | Fam Cancer | 2021 |
| 33794268 | Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome. | Gastroenterology | 2021 |
| 33763780 | Correction to: Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al. | Fam Cancer | 2021 |
| 35070436 | Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report. | J Gastrointest Oncol | 2021 |
| 34994613 | Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs). | JCO Precis Oncol | 2021 |
| 34902833 | A Case of Microsatellite Instability-High Colon Cancer in a Young Woman With Familial Adenomatous Polyposis. | J Natl Compr Canc Netw | 2021 |
| 34666312 | NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. | J Natl Compr Canc Netw | 2021 |
| 34625409 | Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. | Cancer Prev Res (Phila) | 2021 |
| 34010053 | A Case-Based Approach to Understanding Complex Genetic Information in an Evolving Landscape. | Am Soc Clin Oncol Educ Book | 2021 |
| 33406487 | Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2021 |
| 33097490 | Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing <i>SMAD4</i>/<i>BMPR1A</i> Variant. | Cancer Prev Res (Phila) | 2021 |
| 33439686 | Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer. | JCO Oncol Pract | 2021 |
| 32743791 | Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al. | Fam Cancer | 2021 |
| 31622623 | Precision Treatment and Prevention of Colorectal Cancer-Hope or Hype? | Gastroenterology | 2020 |
| 32051178 | A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors. | Cancer Prev Res (Phila) | 2020 |
| 31857714 | Identification of Lynch syndrome by microsatellite instability and mismatch repair deficiency testing on colorectal adenomas. | Eur J Hum Genet | 2020 |
| 31848936 | Correction to: Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk. | J Cancer Educ | 2020 |
| 33233566 | Effect of High-Dose vs Standard-Dose Vitamin D<sub>3</sub> Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial. | Cancers (Basel) | 2020 |
| 32997573 | Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm<sub>5</sub> Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing. | J Clin Oncol | 2020 |
| 32259785 | NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. | J Natl Compr Canc Netw | 2020 |
| 32534636 | Aspirin for Lynch syndrome: a legacy of prevention. | Lancet | 2020 |
| 31615790 | Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome. | Cancer Epidemiol Biomarkers Prev | 2020 |